214 related articles for article (PubMed ID: 17572091)
21. Protein engineering modulates the transport properties and ion selectivity of the pores formed by staphylococcal gamma-haemolysins in lipid membranes.
Comai M; Dalla Serra M; Coraiola M; Werner S; Colin DA; Monteil H; Prévost G; Menestrina G
Mol Microbiol; 2002 Jun; 44(5):1251-67. PubMed ID: 12068809
[TBL] [Abstract][Full Text] [Related]
22. Lethal factor is not required for Bacillus anthracis virulence in guinea pigs and rabbits.
Levy H; Weiss S; Altboum Z; Schlomovitz J; Rothschild N; Blachinsky E; Kobiler D
Microb Pathog; 2011 Nov; 51(5):345-51. PubMed ID: 21791242
[TBL] [Abstract][Full Text] [Related]
23. Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin.
Sapra R; Gaucher SP; Lachmann JS; Buffleben GM; Chirica GS; Comer JE; Peterson JW; Chopra AK; Singh AK
Microb Pathog; 2006; 41(4-5):157-67. PubMed ID: 16950595
[TBL] [Abstract][Full Text] [Related]
24. Curcumin protects mice from Staphylococcus aureus pneumonia by interfering with the self-assembly process of α-hemolysin.
Wang J; Zhou X; Li W; Deng X; Deng Y; Niu X
Sci Rep; 2016 Jun; 6():28254. PubMed ID: 27345357
[TBL] [Abstract][Full Text] [Related]
25. The N-terminal amino-latch region of Hlg2 component of staphylococcal bi-component γ-haemolysin is dispensable for prestem release to form β-barrel pores.
Takeda K; Tanaka Y; Kaneko J
J Biochem; 2020 Oct; 168(4):349-354. PubMed ID: 32330256
[TBL] [Abstract][Full Text] [Related]
26. Interaction of Serratia marcescens hemolysin (ShlA) with artificial and erythrocyte membranes. Demonstration of the formation of aqueous multistate channels.
Schönherr R; Hilger M; Broer S; Benz R; Braun V
Eur J Biochem; 1994 Jul; 223(2):655-63. PubMed ID: 8055936
[TBL] [Abstract][Full Text] [Related]
27. Interactions of high-affinity cationic blockers with the translocation pores of B. anthracis, C. botulinum, and C. perfringens binary toxins.
Bezrukov SM; Liu X; Karginov VA; Wein AN; Leppla SH; Popoff MR; Barth H; Nestorovich EM
Biophys J; 2012 Sep; 103(6):1208-17. PubMed ID: 22995493
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of anthrax protective antigen outside and inside the cell.
Backer MV; Patel V; Jehning BT; Claffey KP; Karginov VA; Backer JM
Antimicrob Agents Chemother; 2007 Jan; 51(1):245-51. PubMed ID: 17074791
[TBL] [Abstract][Full Text] [Related]
29. α-Hemolysin activity of methicillin-susceptible Staphylococcus aureus predicts ventilator-associated pneumonia.
Stulik L; Malafa S; Hudcova J; Rouha H; Henics BZ; Craven DE; Sonnevend AM; Nagy E
Am J Respir Crit Care Med; 2014 Nov; 190(10):1139-48. PubMed ID: 25303310
[TBL] [Abstract][Full Text] [Related]
30. Further study on the two pivotal parts of Hlg2 for the full hemolytic activity of staphylococcal gamma-hemolysin.
Yokota K; Sugawara N; Nariya H; Kaneko J; Tomita T; Kamio Y
Biosci Biotechnol Biochem; 1998 Sep; 62(9):1745-50. PubMed ID: 9805375
[TBL] [Abstract][Full Text] [Related]
31. Interaction of the noncovalent molecular adapter, beta-cyclodextrin, with the staphylococcal alpha-hemolysin pore.
Gu LQ; Bayley H
Biophys J; 2000 Oct; 79(4):1967-75. PubMed ID: 11023901
[TBL] [Abstract][Full Text] [Related]
32. Solution Structures of
Michelman-Ribeiro A; Rubinson KA; Silin V; Kasianowicz JJ
Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941724
[TBL] [Abstract][Full Text] [Related]
33. Dissecting the role of ADAM10 as a mediator of Staphylococcus aureus α-toxin action.
von Hoven G; Rivas AJ; Neukirch C; Klein S; Hamm C; Qin Q; Meyenburg M; Füser S; Saftig P; Hellmann N; Postina R; Husmann M
Biochem J; 2016 Jul; 473(13):1929-40. PubMed ID: 27147619
[TBL] [Abstract][Full Text] [Related]
34. Cyclodextrin derivatives as anti-infectives.
Karginov VA
Curr Opin Pharmacol; 2013 Oct; 13(5):717-25. PubMed ID: 24011515
[TBL] [Abstract][Full Text] [Related]
35. Baicalin protects mice from Staphylococcus aureus pneumonia via inhibition of the cytolytic activity of α-hemolysin.
Qiu J; Niu X; Dong J; Wang D; Wang J; Li H; Luo M; Li S; Feng H; Deng X
J Infect Dis; 2012 Jul; 206(2):292-301. PubMed ID: 22551812
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.
Little SF; Webster WM; Fisher DE
FEMS Immunol Med Microbiol; 2011 Jun; 62(1):11-22. PubMed ID: 21231965
[TBL] [Abstract][Full Text] [Related]
37. Chimeric mutants of staphylococcal hemolysin, which act as both one-component and two-component hemolysin, created by grafting the stem domain.
Ghanem N; Kanagami N; Matsui T; Takeda K; Kaneko J; Shiraishi Y; Choe CA; Uchikubo-Kamo T; Shirouzu M; Hashimoto T; Ogawa T; Matsuura T; Huang PS; Yokoyama T; Tanaka Y
FEBS J; 2022 Jun; 289(12):3505-3520. PubMed ID: 35030303
[TBL] [Abstract][Full Text] [Related]
38. Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy.
Sherer K; Li Y; Cui X; Eichacker PQ
Am J Respir Crit Care Med; 2007 Feb; 175(3):211-21. PubMed ID: 17095744
[TBL] [Abstract][Full Text] [Related]
39. Anthrax protective antigen: prepore-to-pore conversion.
Miller CJ; Elliott JL; Collier RJ
Biochemistry; 1999 Aug; 38(32):10432-41. PubMed ID: 10441138
[TBL] [Abstract][Full Text] [Related]
40. The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits.
Levy H; Weiss S; Altboum Z; Schlomovitz J; Rothschild N; Glinert I; Sittner A; Kobiler D
Microb Pathog; 2012 Jan; 52(1):55-60. PubMed ID: 22020310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
